Biogen CEOMichel Vounatsos to Resign

The move comes as the company tries to chart a new path after Medicare refused to cover Aduhelm for its new Alzheimer’s drug. Biogen CEOMichel Vounatsos to Resign

Edmund DeMarche is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button